NCT05240898

URI: https://gptkb.org/entity/NCT05240898

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:clinical_trial
gptkbp:clinicalTrialPhase	Phase 3
gptkbp:clinicalTrialsGovId	gptkb:NCT05240898
gptkbp:conditionStudied	gptkb:Alzheimer_Disease
gptkbp:estimatedEnrollment	3300
gptkbp:intervention	gptkb:Donanemab
gptkbp:location	gptkb:Australia gptkb:Canada gptkb:Europe gptkb:United_States
gptkbp:officialName	gptkb:A_Study_of_Donanemab_(LY3002813)_in_Participants_With_Preclinical_Alzheimer’s_Disease_(TRAILBLAZER-ALZ_3)
gptkbp:primaryCompletionDate	2027-06-01
gptkbp:sponsor	gptkb:Eli_Lilly_and_Company
gptkbp:startDate	2022-03-01
gptkbp:status	Recruiting
gptkbp:studyType	Interventional
gptkbp:bfsParent	gptkb:KSQ-001EX
gptkbp:bfsLayer	6
http://www.w3.org/2000/01/rdf-schema#label	NCT05240898